A review of prospective pathways and impacts of COVID-19 on the accessibility, safety, quality, and affordability of essential medicines and vaccines for universal health coverage in Africa.

摘要: Background The ongoing pandemic of coronavirus disease 2019 (COVID-19) has the potential to reverse progress towards global targets. This study examines risks that COVID-19 poses equitable access essential medicines and vaccines (EMV) for universal health coverage in Africa. Methods We searched medical databases grey literature up 2 October 2020 studies reporting data on prospective pathways innovative strategies relevant assessment management emerging accessibility, safety, quality, affordability EMV context pandemic. used resulting pool evidence support our analysis draw policy recommendations mitigate improve preparedness future crises. Results Of 310 records screened, 134 were included analysis. found disruption international system affects more immediately capability low- middle-income countries acquire basket EMV. may facilitate dishonesty fraud, increasing propensity patients take substandard falsified drugs. Strategic regional cooperation form joint tenders contract awarding, price negotiation supplier selection, as well market research, monitoring, evaluation could supply, affordability, safety Sustainable financing along with technology transfer substantial investment research development are needed minimize vulnerability African arising from their dependence imported To ensure access, community-based such mobile clinics fees exemptions vulnerable under-served segments society might need be considered. Strategies task delegation telephone triage help reduce physician workload. coupled payments risk allowance frontline healthcare workers health-literate organization appropriate use Conclusions Innovative sustainable informed by comparative increasingly local economic, social, demographic, epidemiological potentials accounted national responses.